Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review

Tyrosine kinase inhibitors are widely used as targeted treatments for various malignancies. Sorafenib is an orally active tyrosine kinase inhibitor that blocks the signaling pathways of several growth factors. Its use is approved for various malignancies such as unresectable hepatocellular carcinoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Dae Hyun, Yoon, Jai Hoon, Jun, Dae Won, Lee, Oh Young, Yoon, Byung Chul, Lee, Hang Rak, Kim, Kyung Soo, Choi, Ho Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035694/
https://www.ncbi.nlm.nih.gov/pubmed/37383059
http://dx.doi.org/10.17998/jlc.20.1.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035694/
https://www.ncbi.nlm.nih.gov/pubmed/37383059
http://dx.doi.org/10.17998/jlc.20.1.67

Ejemplares similares